Results 331 to 340 of about 18,892,704 (362)
Some of the next articles are maybe not open access.

Galectin-3 and cancer (Review).

International Journal of Oncology, 2004
Galectin-3 is a pleiotropic carbohydrate-binding protein involved in a variety of normal and pathological biological processes. Its carbohydrate-binding properties constitute the basis for cell-cell and cell-matrix interactions and cancer progression. Modulation of galectin-3 expression in cancer cells has indeed been reported.
Califice, Stéphane   +2 more
openaire   +3 more sources

Extracellular functions of galectin-3

Glycoconjugate Journal, 2002
Galectin-3 has been suspected of modulating cell to extracellular matrix interactions in a novel fashion ever since it was first described. However, the rapid accumulation of research data in just the last 8 years alone has completely changed our perspective of this multifunctional protein.
Josiah, Ochieng   +2 more
openaire   +2 more sources

Galectin-3

Cardiovascular Drugs and Therapy, 2014
Myocardial galectin-3 is upregulated upon cardiac stressors such as angiotensin II and pressure overload leading to cardiac remodeling and heart failure. The expression level of galectin-3 mirrors the progression and severity of heart failure and therefore, galectin-3 is being used as a biomarker for heart failure.
de Boer, Rudolf A.   +7 more
openaire   +1 more source

Nucleocytoplasmic Shuttling of Galectin-3

2014
A large number of observations on the nuclear versus cytoplasmic distribution of galectin-3 have been reported, correlating the presence or absence of the protein in a particular compartment of the cell to various parameters such as source of the cells under study, specific cell type, culture conditions, proliferation status of the cell/culture, or ...
Eric J, Arnoys   +2 more
openaire   +2 more sources

Endogenous galectin-3 expression levels modulate immune responses in galectin-3 transgenic mice

Molecular Immunology, 2015
Galectin-3 (Gal-3), a β-galactoside-binding mammalian lectin, is involved in cancer progression and metastasis. However, there is an unmet need to identify the underlying mechanisms of cancer metastasis mediated by endogenous host galectin-3. Galectin-3 is also known to be an important regulator of immune responses.
Aparna D. Chaudhari   +3 more
openaire   +2 more sources

HH1-1, a novel Galectin-3 inhibitor, exerts anti-pancreatic cancer activity by blocking Galectin-3/EGFR/AKT/FOXO3 signaling pathway.

Carbohydrate Polymers, 2019
Pancreatic ductal adenocarcinoma is a highly malignant gastrointestinal tumor. Molecular targeting therapy for pancreatic cancer is still limited.
Yanli Yao   +7 more
semanticscholar   +1 more source

Targeting galectin-driven regulatory circuits in cancer and fibrosis

Nature Reviews Drug Discovery, 2023
Karina V Mariño   +2 more
exaly  

Galectin 3

1997
A. Neil Barclay   +5 more
openaire   +1 more source

Galectin 3

2000
Clare M. Isacke, Michael A. Horton
openaire   +1 more source

Galectin-3

2012
Rudolf Boer   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy